Management of Hyper IgE Syndrome

Introduction to Hyper IgE Syndrome

The American Academy of Allergy, Asthma, and Immunology recommends aggressive management of complications, with particular focus on controlling infections through prophylactic and therapeutic antimicrobial agents in patients with Hyper IgE Syndrome 1, 2

Type 1 Hyper IgE Syndrome is caused by STAT3 mutations, characterized by skin infections, lung abscesses, skeletal abnormalities, and dental issues, according to the American College of Medical Genetics 2, 3
Type 2 Hyper IgE Syndrome is often caused by DOCK8 mutations, characterized by severe allergic manifestations, viral infections, and no skeletal/dental abnormalities, as reported by the National Institute of Allergy and Infectious Diseases 4

Aggressive therapeutic and prophylactic antibiotic therapy is the cornerstone of management for all Hyper IgE Syndrome types, as recommended by the Infectious Diseases Society of America 1, 2
Antifungal prophylaxis should be considered, particularly for patients with recurrent fungal infections, according to the American Society for Microbiology 1, 2
Regular monitoring for early detection of infections is essential to prevent complications, as stated by the Centers for Disease Control and Prevention 3

Monitor for skeletal complications, such as scoliosis and fracture risk, as these patients have a high risk of fracture with minor trauma, according to the American Academy of Orthopaedic Surgeons 1, 2
Dental care, including extraction of retained primary teeth, is necessary to prevent dental complications, as recommended by the American Dental Association 1, 2
IVIG therapy may be considered in selected cases with impaired specific antibody responses, though evidence is mixed regarding immunologic improvement, as reported by the National Institute of Allergy and Infectious Diseases 2, 3

IgG replacement therapy should be provided for patients with DOCK8 deficiency who demonstrate poor antibody production, according to the Immune Deficiency Foundation 1, 2
Close monitoring for lymphoma and vasculopathy is essential, as these are life-threatening complications, as stated by the American Cancer Society 2, 3

Hematopoietic stem cell transplantation (HSCT) should be considered for both forms of Hyper IgE Syndrome, as recommended by the American Society for Blood and Marrow Transplantation 2, 3
For Type 2 Hyper IgE Syndrome, HSCT has shown successful outcomes with restoration of immune function and resolution of eosinophilia, according to the National Institute of Allergy and Infectious Diseases 2, 3

Pulmonary function should be regularly monitored, as patients can have a progressive decrease of lung function due to frequent pneumonias, as stated by the American Thoracic Society 1, 2

IVIG efficacy is mixed, with some studies showing clinical improvement while others show no benefit in immunologic function, as reported by the National Institute of Allergy and Infectious Diseases 2, 3
The decision for HSCT should be made early, particularly for Type 2 Hyper IgE Syndrome, before development of significant complications, according to the American Society for Blood and Marrow Transplantation 2, 3